Guest guest Posted March 16, 2011 Report Share Posted March 16, 2011 GNS Healthcare And Biogen Idec Identify Novel, Patient-Specific Drug Targets For Rheumatoid Arthritis Main Category: Arthritis / Rheumatology Article Date: 14 Mar 2011 - 4:00 PDT GNS Healthcare, Inc., (GNS) the leading healthcare analytics company focused on enabling personalized medicine to improve human health, announced the publication of results from a study focused on identifying novel drug targets for the one-third of rheumatoid arthritis patients who do not respond to leading anti-TNF therapies. ****************************************** Read the rest of the article here: http://www.medicalnewstoday.com/articles/219042.php Not an MD Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.